[Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D014149:Tranquilizing Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D004299:Dopamine beta-Hydroxylase
Neuroleptyki, inhibitory monoaminooksydazy i inhibitory beta-hydroksylazy dopaminowej: ich działanie i interakcje.